Psychopathological and personality features in primary Sjögren's syndrome-associations with autoantibodies to neuropeptides

Rheumatology

Volumn 49, Issue 9, 2010, Pages 1762-1769

  Karaiskos, Dimitrios ^a   Mavragani, Clio P ^b   Sinno, Maria Hamze ^c   Déchelotte, Pierre ^c   Zintzaras, Elias ^d   Skopouli, Fotini N ^e   Fetissov, Sergueï O ^c   Moutsopoulos, Haralampos M ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITÉ DE ROUEN   (France)

^d UNIVERSITY OF THESSALY   (Greece)

^e HAROKOPIO UNIVERSITY   (Greece)

Author keywords

MSH; Antibodies to neuropeptides; Anxiety; Depression; Personality; Psychopathology; Sj gren's syndrome

Indexed keywords

ALPHA INTERMEDIN; AUTOANTIBODY; NEUROPEPTIDE; OXYTOCIN; VASOPRESSIN;

ADULT; ANTIBODY BLOOD LEVEL; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISTRESS SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOCHONDRIASIS; HYPOPHYSIS; HYPOTHALAMUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROSIS; PERSONALITY; PRIORITY JOURNAL; PSYCHOSIS; SJOEGREN SYNDROME; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

AGED; ALPHA-MSH; ANXIETY DISORDERS; AUTOANTIBODIES; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPEPTIDES; PERSONALITY; SJOGREN'S SYNDROME;

EID: 77955723007     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq158     Document Type: Article

References (38)

1. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med 2004;164:1275-84.
2. Angelopoulos N, Drosos AA, Kosovitsa G, Toli E, Liakos A. Personality and psychopathology in patients with primary Sjogren's syndrome. Ter Arkh 1988;60:49-52.
3. Drosos AA, Angelopoulos NV, Liakos A, Moutsopoulos HM. Personality structure disturbances and psychiatric manifestations in primary Sjogren's syndrome. J Autoimmun 1989;2:489-93.
4. Champey J, Corruble E, Gottenberg JE et al. Quality of life and psychological status in patients with primary Sjogren's syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 2006;55:451-7.
5. Mauch E, Volk C, Kratzsch G et al. Neurological and neuropsychiatric dysfunction in primary Sjogren's syndrome. Acta Neurol Scand 1994;89:31-5.
6. Mukai M, Sagawa A, Baba Y et al. Neuro-psychiatric symptom associated with primary Sjogren's syndrome. Ryumachi 1990;30:109-18.
7. Valtysdottir ST, Gudbjornsson B, Hallgren R, Hetta J. Psychological well-being in patients with primary Sjogren's syndrome. Clin Exp Rheumatol 2000;18: 597-600.
8. Valtysdottir ST, Gudbjornsson B, Lindqvist U, Hallgren R, Hetta J. Anxiety and depression in patients with primary Sjogren's syndrome. J Rheumatol 2000;27:165-9.
9. Valtysdottir ST, Wide L, Hallgren R. Mental wellbeing and quality of sexual life in women with primary Sjogren's syndrome are related to circulating dehydroepiandrosterone sulphate. Ann Rheum Dis 2003;62:875-9.
10. Vriezekolk JE, Geenen R, Hartkamp A et al. Psychological and somatic predictors of perceived and measured 1768 www.rheumatology.oxfordjournals.org ocular dryness of patients with primary Sjogren's syndrome. J Rheumatol 2005;32:2351-5.
11. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002;46:741-7.
12. Karaiskos D, Mavragani CP, Makaroni S et al. Stress, coping strategies and social support in patients with primary Sjogren's syndrome prior to disease onset: a retrospective case control study. Ann Rheum Dis 2009;68: 40-6.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington: 4th edition, text revision. 2004.
14. Martin N, Goodwin G, Fairburn C et al. A population-based study of personality in 34,000 sib-pairs. Twin Res 2000;3: 310-5.
15. Eysenck HJ, Eysenck SBG. Manual of the EPQ. London: Stoughton Educational, 1975.
16. Hettema JM, Neale MC, Myers JM, Prescott CA, Kendler KS. A population-based twin study of the relationship between neuroticism and internalizing disorders. Am J Psychiatry 2006;163:857-64.
17. Wray NR, Birley AJ, Sullivan PF, Visscher PM, Martin NG. Genetic and phenotypic stability of measures of neuroticism over 22 years. Twin Res Hum Genet 2007;10: 695-702.
18. Eysenck SB, Eysenck HJ. The measurement of psychoticism: a study of factor stability and reliability. Br J Soc Clin Psychol 1968;7:286-94.
19. Johnson EO, Kostandi M, Moutsopoulos HM. Hypothalamic-pituitary-adrenal axis function in Sjogren's syndrome: mechanisms of neuroendocrine and immune system homeostasis. Ann N Y Acad Sci 2006;1088:41-51.
20. Johnson EO, Moutsopoulos HM. Neuroendocrine manifestations in Sjogren's syndrome. Relation to the neurobiology of stress. Ann N Y Acad Sci 2000;917:797-808.
21. Keller PA, McCluskey A, Morgan J, O'Connor SM. The role of the HPA axis in psychiatric disorders and CRF antagonists as potential treatments. Arch Pharm 2006;339: 346-55.
22. Fetissov SO, Hallman J, Nilsson I, Lefvert AK, Oreland L, Hokfelt T. Aggressive behavior linked to corticotropin-reactive autoantibodies. Biol Psychiatry 2006;60:799-802.
23. Fetissov SO, Hallman J, Oreland L et al. Autoantibodies against alpha-MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proc Natl Acad Sci USA 2002; 99:17155-60.
24. Fetissov SO, Harro J, Jaanisk M et al. Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci USA 2005; 102:14865-70.
25. Sinno MH, Rego JC, Coeffier M et al. Regulation of feeding and anxiety by alpha-MSH reactive autoantibodies. Psychoneuroendocrinology 2009;34:140-9.
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12: 189-98.
27. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
28. Zung WW. A Self-Rating Depression Scale. Arch Gen Psychiatry 1965;12:63-70.
29. Spielberger CD, Gorsuch RL, Luchene RE. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto, CA: Consulting Psychologists Press, 1970.
30. Pilowsky I. Dimensions of hypochondriasis. Br J Psychiatry 1967;113:89-93.
31. Derogatis LR. SCL-90: Administration, scoring and procedures. Manual for the revised version. Baltimore: Clinical Psychometric Research, 1983.
32. Cooper J. The Leyton obsessional inventory. Psychol Med 1970;1:48-64.
33. Stalikas A. Psychometric tools in Greece. Athens: Ellinika Grammata, 2002.
34. Compton MT, Carter T, Kryda A, Goulding SM, Kaslow NJ. The impact of psychoticism on perceived hassles, depression, hostility, and hopelessness in non-psychiatric African Americans. Psychiatry Res 2008; 159:215-25.
35. Stevenson HA, Jones ME, Rostron JL, Longman LP, Field EA. UK patients with primary Sjogren's syndrome are at increased risk from clinical depression. Gerodontology 2004;21:141-5.
36. Zautra AJ, Parrish BP, Van Puymbroeck CM et al. Depression history, stress, and pain in rheumatoid arthritis patients. J Behav Med 2007;30:187-97.
37. Kishi T, Elmquist JK. Body weight is regulated by the brain: a link between feeding and emotion. Mol Psychiatry 2005;10:132-46.
38. van der Kraan M, Adan RA, Entwistle ML, Gispen WH, Burbach JP, Tatro JB. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 1998; 139:2348-55.